✦ LIBER ✦

Global risk assessment for lipid therapy to prevent coronary heart disease

✍ Scribed by Caitlin M. Nass; Stephen D. Wiviott; Jerilyn K. Allen; Wendy S. Post; Roger S. Blumenthal

Publisher: Springer
Year: 2000
Tongue: English
Weight: 384 KB
Volume: 2
Category: Article
ISSN: 1523-3782
DOI: 10.1007/s11886-000-0056-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibiotic therapy for treatment ofChlam

Antibiotic therapy for treatment ofChlamydiato prevent coronary heart disease events

✍ Joseph B. Muhlestein 📂 Article 📅 2000 🏛 Current Science Inc. 🌐 English ⚖ 276 KB

Emerging inflammatory markers for assess

Emerging inflammatory markers for assessing coronary heart disease risk

✍ Marshall A. Corson 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 293 KB

Lipids, lipoproteins, and coronary heart

Lipids, lipoproteins, and coronary heart disease: Implications for antihypertensive therapy

✍ M. D. Feher; D. J. Betteridge 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 628 KB

There is now considerable evidence that treatment of abnormalities of lipids and lipoproteins reduces the incidence of coronary heart disease (CHD). Treatment of hypertension, another major cardiovascular risk factor, has not been shown to have the same impact on CHD. Possible explanations for this

Recommendation for an exercise prescript

Recommendation for an exercise prescription to prevent coronary heart disease

✍ Atsuko Koyanagi; Kikuko Yamamoto; Kumiko Nishijima; Kenji Kurahara; Yukiko Kurok 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 232 KB

Hormone replacement therapy for preventi

Hormone replacement therapy for prevention of coronary heart disease: Current evidence

✍ P. Sheena Khurana; Charanjit Khurana; Judith Hsia 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 237 KB

Modifying serum lipids to prevent corona

Modifying serum lipids to prevent coronary heart disease: Do we have a consensus?

✍ Steven A. Grover 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 490 KB